Clinical Trials Directory

Trials / Completed

CompletedNCT03980015

Inflammatory Responses in Solitary and Multiple Erythema Migrans

Inflammatory Responses in Borrelia Afzelii Culture Positive Patients With Early Disseminated or Early Localized Lyme Borreliosis

Status
Completed
Phase
Study type
Observational
Enrollment
134 (actual)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators will evaluate differences in host immune responses (levels of cytokines and chemokines, representative of innate, Th1, and Th17 immune responses) in acute sera from adult patients with solitary or multiple erythema migrans.

Conditions

Interventions

TypeNameDescription
OTHERantibiotic treatmentPatients were treated with: ceftriaxone intravenously 2 g OD for 14 days or doxycycline orally 100 mg bid for 10 to 14 days or cefuroxime axetil orally 500 mg bid for 14 days or amoxicillin orally 500 mg tid for 14 days

Timeline

Start date
2006-06-01
Primary completion
2016-12-31
Completion
2019-05-31
First posted
2019-06-10
Last updated
2019-06-11

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT03980015. Inclusion in this directory is not an endorsement.

Inflammatory Responses in Solitary and Multiple Erythema Migrans (NCT03980015) · Clinical Trials Directory